MHC-binding peptides as immunotherapeutics for cancer

H. Kobayashi, R. Kennedy, J. Lu, E. Davila, E. Celis

Research output: Contribution to journalArticle

7 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)105-110
Number of pages6
JournalImmunological Investigations
Volume29
Issue number2
DOIs
StatePublished - Jan 1 2000
Externally publishedYes

Fingerprint

Immunologic Cytotoxicity
Neoplasm Proteins
ErbB-2 Receptor
Histocompatibility Antigens Class I
Carcinoembryonic Antigen
Histocompatibility Antigens Class II
Cytotoxic T-Lymphocytes
Neoplasm Antigens
Protein Binding
Immunotherapy
Epitopes
Peptides
Neoplasms
MHC binding peptide

ASJC Scopus subject areas

  • Immunology

Cite this

MHC-binding peptides as immunotherapeutics for cancer. / Kobayashi, H.; Kennedy, R.; Lu, J.; Davila, E.; Celis, E.

In: Immunological Investigations, Vol. 29, No. 2, 01.01.2000, p. 105-110.

Research output: Contribution to journalArticle

Kobayashi, H. ; Kennedy, R. ; Lu, J. ; Davila, E. ; Celis, E. / MHC-binding peptides as immunotherapeutics for cancer. In: Immunological Investigations. 2000 ; Vol. 29, No. 2. pp. 105-110.
@article{ed0ae94505d5433b8b173f7062464357,
title = "MHC-binding peptides as immunotherapeutics for cancer",
author = "H. Kobayashi and R. Kennedy and J. Lu and E. Davila and E. Celis",
year = "2000",
month = "1",
day = "1",
doi = "10.3109/08820130009062291",
language = "English (US)",
volume = "29",
pages = "105--110",
journal = "Immunological Investigations",
issn = "0882-0139",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - MHC-binding peptides as immunotherapeutics for cancer

AU - Kobayashi, H.

AU - Kennedy, R.

AU - Lu, J.

AU - Davila, E.

AU - Celis, E.

PY - 2000/1/1

Y1 - 2000/1/1

UR - http://www.scopus.com/inward/record.url?scp=0034069107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034069107&partnerID=8YFLogxK

U2 - 10.3109/08820130009062291

DO - 10.3109/08820130009062291

M3 - Article

C2 - 10854176

AN - SCOPUS:0034069107

VL - 29

SP - 105

EP - 110

JO - Immunological Investigations

JF - Immunological Investigations

SN - 0882-0139

IS - 2

ER -